Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K
Contraindications for bulk-forming laxatives include intestinal obstruction, faecal impaction, colonic atony, and difficulty swallowing
Structurally, Retatrutide is a 39-residue peptide made by solid-phase synthesis and incorporates three non-coded amino acid modifications: 2-aminoisobutyric acid (Aib) at positions 2 and 20 for DPP-4 resistance, plus -methyl-leucine (MeL) at position 13 to optimize GIP receptor activity
Influence Fat Metabolism: While complex, GIP agonism is thought to contribute to the overall metabolic rebalancing that promotes weight loss and improves insulin sensitivity
The findings showed that 2.4 mg each of semaglutide and cagrilintide resulted in a 23% reduction in body weight, whereas 15 mg of tirzepatide resulted in a 25.5% reduction